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Background
Evidence based policy-making has been promoted as a
means of ensuring better outcomes but what counts as
evidence in policy-making lies within a spectrum of
expert knowledge through scientifically generated infor-
mation. Different actors provide varying degrees of sup-
port for and use of different types of evidence in policy
development. Since not all forms of evidence share an
equal validity or weighting for policy-makers, it is impor-
tant to understand the key factors that influence their
choice of evidence.
Materials and methods
A retrospective cross-sectional study was carried out at
the national level in Nigeria. A case-study approach was
used and the Nigerian Integrated Maternal Newborn
and Child Health (IMNCH) strategy was selected
because it met the criteria of being: (i) recently devel-
oped (<10 years old); and (ii) of international promi-
nence. Two frameworks were used for conceptualization
and data analysis namely: (i) framework for analyzing
the role of evidence in policy making developed by Mir-
zoev et al., in 2012, and (ii) the policy triangle. They
were used to explore the key contextual and participa-
tory influences on choice of evidence in developing the
IMNCH strategy. Data was collected through review of
relevant national documents and in-depth interviews of
purposefully selected key policy and decision makers.
Thematic analysis was applied.
Results
The breadth of evidence used was wide, ranging from
expert opinions to systematic reviews. The choice of dif-
ferent types of evidence was found to overlap across actor
categories. Key influences over actors’ choice of evidence
were: (i) perceived robustness of evidence - comprehen-
sive, representative, recent, scientifically sound; (ii) roles in
evidence process, i.e. their degree and level of participation
in evidence generation and dissemination, vis-à-vis their
role in the policy process; and (iii) contextual factors such
as global agenda and influence, timeline for strategy devel-
opment, availability of resources for evidence generation,
and lessons from previously unsuccessful policies/plans.
Conclusion
Actors’ choice of evidence in policy making is influenced
not only by the characteristics of evidence, but on the
roles these actors play in the process, their power to influ-
ence the policy, and the context in which evidence is used.
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